Latest Articles
Doctors advocate for pain transparency in gynaecological procedures - Cayman Compass
Doctors advocate for pain transparency in gynaecological procedures Cayman Compass
Published: June 4, 2025, 4:58 a.m.
Doctor reveals 5 daily diet changes that could help ease painful condition - Bristol Live
Doctor reveals 5 daily diet changes that could help ease painful condition Bristol Live
Published: June 3, 2025, 4:02 p.m.
Impact of the Microcystic, Elongated, and Fragmented (MELF) Invasion Pattern on prognosis in Endometrial Carcinoma: A Comprehensive Meta-Analysis - Frontiers
Impact of the Microcystic, Elongated, and Fragmented (MELF) Invasion Pattern on prognosis in Endometrial Carcinoma: A Comprehensive Meta-Analysis Frontiers
Published: June 3, 2025, 2:36 p.m.
CBD Life Sciences Inc. (CBDL) Releases New CBD Suppositories for Vaginal & Rectal Relief - Newswire :) Press Release Distribution
CBD Life Sciences Inc. (CBDL) Releases New CBD Suppositories for Vaginal & Rectal Relief Newswire :) Press Release Distribution
Published: June 3, 2025, noon
Doctor reveals 5 daily diet changes that could help ease painful condition - Surrey Live
Doctor reveals 5 daily diet changes that could help ease painful condition Surrey Live
Published: June 3, 2025, 11:01 a.m.
CBD Life Sciences Inc. (CBDL) Releases New CBD Suppositories for Vaginal & Rectal Relief - The Globe and Mail
CBD Life Sciences Inc. (CBDL) Releases New CBD Suppositories for Vaginal & Rectal Relief The Globe and Mail
Published: June 3, 2025, 8 a.m.
Writer shares troubling story about invisible threat impacting neighborhood where she grew up: 'We lived in the shadow' - MSN
Writer shares troubling story about invisible threat impacting neighborhood where she grew up: 'We lived in the shadow' MSN
Published: June 3, 2025, 6:39 a.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - BioSpace
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial BioSpace
Published: June 2, 2025, 11:48 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - GlobeNewswire
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial GlobeNewswire
Published: June 2, 2025, 6:32 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - Yahoo Finance
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial Yahoo Finance
Published: June 2, 2025, 6:30 p.m.
Link copied to clipboard!